Aspira Pathlab

{
  "main_header": {
    "sid": 1002885,
    "name": "Aspira Pathlab",
    "stock_name": "Aspira Pathlab",
    "full_name": "Aspira Pathlab & Diagnostics Ltd",
    "name_url": "stocks-analysis/aspira-pathlab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "129.97",
    "chg": -3.14,
    "chgp": "-2.36%",
    "dir": -1,
    "prev_price": "133.11",
    "mcapval": "138.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540788,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE500C01017",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "17:55 PM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": 3481,
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 138.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-of-rs13899-4203275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AspiraPathlabDi_priceRelatedfactors_4203275.png",
        "date": "2026-09-24 09:49:16",
        "description": "Surging to a fresh 52-week and all-time high of Rs 138.99 on 24 Sep 2026, Aspira Pathlab & Diagnostics Ltd has demonstrated remarkable price momentum, rallying over 44.5% in just the past 10 trading sessions. This impressive run has propelled the stock well above all key moving averages, underscoring a strong technical foundation amid a broader market environment that remains subdued."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 138.99 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-all-time-high-at-rs13899-4203198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AspiraPathlabDi_priceRelatedfactors_4203198.png",
        "date": "2026-09-24 09:34:30",
        "description": "Extending its winning streak to 10 consecutive sessions, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 138.99 on 24 Sep 2026, marking a remarkable 44.54% return over this period and significantly outpacing the Sensex, which declined 0.69% on the same day."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4196163",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AspiraPathlabDi_mojoScore_4196163.png",
        "date": "2026-09-17 10:11:20",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4180985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AspiraPathlabDi_mojoScore_4180985.png",
        "date": "2026-09-03 10:11:03",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4165910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AspiraPathlabDi_mojoScore_4165910.png",
        "date": "2026-08-23 10:10:27",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4147179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AspiraPathlabDi_mojoScore_4147179.png",
        "date": "2026-08-11 10:10:57",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Aspira Pathlab & Diagnostics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aspira-pathlab-diagnostics-ltd-4142469",
        "imagepath": "",
        "date": "2026-08-07 23:20:59",
        "description": "The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4130189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AspiraPathlabDi_mojoScore_4130189.png",
        "date": "2026-07-31 10:10:03",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-ltd-is-rated-sell-4109015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AspiraPathlabDi_mojoScore_4109015.png",
        "date": "2026-07-20 10:10:41",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date perspective on its performance and outlook."
      }
    ],
    "total": 6181,
    "sid": "1002885",
    "stock_news_url": "https://www.marketsmojo.com/news/aspira-pathlab-diagnostics-1002885"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "16-Sep-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30_Constitution Of Right Issue Committee",
      "datetime": "12-Sep-2026",
      "details": "Enclosed herewith Constitution of Right Issue Committee for proposed right issue",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
      "datetime": "12-Sep-2026",
      "details": "Intimation under Regulation 30 (LODR) -Raising of Funds",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 138.99

2026-09-24 09:49:16

Surging to a fresh 52-week and all-time high of Rs 138.99 on 24 Sep 2026, Aspira Pathlab & Diagnostics Ltd has demonstrated remarkable price momentum, rallying over 44.5% in just the past 10 trading sessions. This impressive run has propelled the stock well above all key moving averages, underscoring a strong technical foundation amid a broader market environment that remains subdued.

Read full news article

Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 138.99 as Momentum Builds Across Timeframes

2026-09-24 09:34:30

Extending its winning streak to 10 consecutive sessions, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 138.99 on 24 Sep 2026, marking a remarkable 44.54% return over this period and significantly outpacing the Sensex, which declined 0.69% on the same day.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-09-17 10:11:20

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-09-03 10:11:03

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-08-23 10:10:27

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-08-11 10:10:57

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for Aspira Pathlab & Diagnostics Ltd?

2026-08-07 23:20:59

The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 12 August 2026....

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-07-31 10:10:03

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-07-20 10:10:41

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

View All News